SAREPTA THERAPEUTICS, INC. Restricted Cash and Investments, Noncurrent
SAREPTA THERAPEUTICS, INC. (SRPT) had Restricted Cash and Investments, Noncurrent of $19.15 million as of 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Investments, Noncurrent
us-gaap:RestrictedCashAndInvestmentsNoncurrent · last filed 2023-11-01
- 2023-09-30: Restricted Cash and Investments, Noncurrent $19.15M.
- 2023-06-30: Restricted Cash and Investments, Noncurrent $19.02M.
- 2023-03-31: Restricted Cash and Investments, Noncurrent $19.02M.
- 2022-12-31: Restricted Cash and Investments, Noncurrent $19.02M.
| Period end | Restricted Cash and Investments, Noncurrent |
|---|---|
| 2023-09-30 | $19.15M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $19.02M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $19.02M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $19.02M 10-Q · filed 2023-11-01 |
| 2022-09-30 | $19.02M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $18.50M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $9.65M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $9.90M 10-K · filed 2023-02-28 |
| 2021-09-30 | $9.31M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $9.31M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $9.31M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $9.31M 10-K · filed 2022-03-01 |
| 2020-09-30 | $9.57M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.57M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $9.57M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $9.57M 10-K · filed 2021-03-01 |
| 2019-09-30 | $9.57M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $9.46M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $6.20M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.00M 10-K · filed 2020-02-26 |
| 2018-03-31 | $784.00K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $784.00K 10-Q · filed 2018-05-03 |
| 2017-09-30 | $784.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $784.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $784.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $784.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $784.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $783.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $783.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $783.00K 10-K · filed 2017-02-28 |
| 2015-09-30 | $11.48M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $783.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $783.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $782.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $647.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $647.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $647.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $647.00K 10-K · filed 2015-02-26 |
| 2013-09-30 | $557.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $557.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $7.25M 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |